|
Market Closed -
Nasdaq
02:30:00 03/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.440 USD | -5.06% |
|
-5.79% | +71.83% |
| 15/10 | Edesa Biotech, Inc. Receives FDA IND Clearance For Phase 2 Clinical Study Of EB06 In Vitiligo | CI |
| 20/08 | Edesa Biotech Launches Public Offering of Common Shares, Warrants | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -5.06% | -5.79% | -36.79% | -52.25% | +71.83% | +31.18% | -28.45% | -95.97% | - | 3.3Cr | |
| -2.37% | -5.03% | -17.14% | +7.96% | +52.97% | +39.49% | +62.39% | +5.22% | - | 6.22TCr | |
| -0.03% | +0.13% | -3.52% | +8.53% | +9.35% | +10.43% | +68.34% | +184.09% | +5,811.01% | 5.49TCr | |
| -0.26% | +1.45% | +12.21% | +15.14% | +19.93% | +19.62% | +95.99% | -15.97% | +258.33% | 5.53TCr | |
| -3.33% | -5.54% | +0.09% | +9.97% | +14.65% | +19.39% | +35.69% | +0.24% | +257.16% | 4.26TCr | |
| -2.45% | -2.59% | +0.89% | +14.32% | +18.91% | +16.36% | +98.45% | +0.82% | +992.77% | 4.11TCr | |
| -1.64% | +2.32% | -8.94% | +0.34% | +136.25% | +219.80% | +789.69% | +491.17% | - | 4.03TCr | |
| -0.15% | +22.29% | +54.19% | +98.54% | +80.81% | +96.57% | +81.44% | +24.03% | +208.24% | 3.31TCr | |
| +0.21% | +1.05% | +5.15% | +2.84% | +11.38% | +14.81% | +46.96% | +13.09% | +158.25% | 3.26TCr | |
| -2.90% | +17.12% | -1.63% | +10.86% | -37.19% | -42.35% | +337.07% | +241.27% | +810.16% | 2.4TCr | |
| -3.45% | -3.58% | -22.27% | +10.98% | +36.96% | +20.89% | -10.20% | -60.93% | - | 2.33TCr | |
| -0.73% | +0.77% | -9.67% | -3.37% | -8.06% | -15.76% | -5.36% | -69.76% | - | 2.2TCr | |
| -0.59% | -4.23% | +8.12% | +12.31% | +15.40% | +10.81% | +144.91% | +185.74% | +2,072.78% | 1.81TCr | |
| -5.81% | -5.24% | +16.66% | +45.60% | +69.71% | +88.00% | +93.77% | -21.63% | +382.80% | 1.62TCr | |
| -1.66% | +1.22% | +14.54% | +27.72% | +38.65% | +43.77% | +68.00% | -16.21% | +115.33% | 1.71TCr | |
| +1.07% | +7.71% | +20.11% | +32.25% | +60.00% | +81.36% | +248.39% | +220.52% | +548.75% | 1.71TCr | |
| -0.91% | +1.56% | +9.26% | +2.08% | - | - | - | - | - | 1.64TCr | |
| -2.94% | +11.62% | +26.59% | +25.42% | +12.58% | +19.39% | -19.08% | -27.36% | +167.07% | 1.54TCr | |
| 0.00% | +2.59% | +2.15% | +12.26% | +180.86% | +165.07% | +348.66% | +1,411.75% | +801.47% | 1.51TCr | |
| +8.67% | +16.86% | +2.41% | +78.89% | +32.90% | -12.65% | - | - | - | 1.43TCr | |
| Average | -1.23% | +3.06% | +3.62% | +18.02% | +43.05% | +43.48% | +136.48% | +137.23% | +968.01% | 2.81TCr | |
| Weighted average by Cap. | -1.24% | +2.61% | +3.42% | +18.44% | +38.81% | +43.43% | +144.87% | +114.84% | +1,271.49% |
- Stock Market
- Stocks
- EDSA Stock
- Sector Edesa Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
